PRX-03140 / Resilience 
Welcome,         Profile    Billing    Logout  
 11 Diseases   1 Trial   1 Trial   2 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PRX-03140 / Resilience
2008-006337-27: A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED,PARALLEL GROUP STUDY TO EVALUATE THEEFFICACY AND SAFETY OF PRX-03140 AS MONOTHERAPY INSUBJECTS WITH ALZHEIMER’S DISEASE

Ongoing
2
75
Europe
PRX-03140, Aricept, Aricept
EPIX Pharmaceuticals, Inc.
Alzheimer\'s Disease
 
 

Download Options